Develops drugs that allow the human body to fight various diseases
CureVac has raised €574M across 6 funding rounds from 3 investors, most recently a Early VC round in Jun 2020. Based in Tübingen, Germany; founded 2000; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-06-16 | Early VC | €300M | KfW | View deal → |
| 2015-11-01 | Series D+ | €100M | Baillie Gifford | View deal → |
| 2015-03-01 | Series D+ | €46M | — | View deal → |
| 2012-09-01 | Series D+ | €80M | — | View deal → |
| 2010-05-01 | Series C | €26M | — | View deal → |
| 2006-01-01 | Series B | €22M | DH Capital | View deal → |
